Abstract: According to one embodiment, a method for producing a directed neutron beam includes producing a voltage of negative polarity of at least ?100 keV on a surface of a deuterated or tritiated target in response to a temperature change of a pyroelectric crystal of less than about 40° C., the pyroelectric crystal having the deuterated or tritiated target coupled thereto, pulsing a deuterium ion source to produce a deuterium ion beam, accelerating the deuterium ion beam to the deuterated or tritiated target to produce a neutron beam, and directing the ion beam onto the deuterated or tritiated target to make neutrons using at least one of a voltage of the pyroelectric crystal, and a high gradient insulator (HGI) surrounding the pyroelectric crystal. The directionality of the neutron beam is controlled by changing the accelerating voltage of the system. Other methods are presented as well.

Abstract: A method of retrieving a tool bit from a tool bit case includes supporting the tool bit with a bit retainer of the tool bit case at an oblique angle relative to a bottom surface of the tool bit case so that a drive portion of the tool bit extends generally away from the bottom surface, engaging the drive portion of the tool bit with a driver while the tool bit is supported by the bit retainer, and removing the tool bit from the bit retainer by manipulating the driver.

Abstract: The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.

Abstract: The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.

Abstract: The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.

Abstract: A method of retrieving a tool bit from a tool bit case includes supporting the tool bit with a bit retainer of the tool bit case at an oblique angle relative to a bottom surface of the tool bit case so that a drive portion of the tool bit extends generally away from the bottom surface, engaging the drive portion of the tool bit with a driver while the tool bit is supported by the bit retainer, and removing the tool bit from the bit retainer by manipulating the driver.

Abstract: This invention pertains to a multi-layered tablet for a triple combination release of active agents to an environment of use. More particularly, the invention pertains to a multi-layered tablet (1) comprising two external drug-containing layers (2 and 3) in stacked arrangement with respect to and on opposite sides of an oral dosage form (4) that provides a triple combination release of at least one active agent. In one embodiment of the invention the dosage form is an osmotic device. In another embodiment of the invention the dosage form is a gastro-resistant coated core. In yet another embodiment of the invention the dosage form is a matrix tablet. In a different embodiment the dosage form is a hard capsule.

Abstract: A device for securing and displaying a saw blade, the device including a body portion having a first through hole adapted to receive a hanger, a cavity for housing a security device, and a locating profile. The device also includes a cover including a second through hole. The body portion and the cover are one structure coupled by a hinge such that the post extends from one of said body portion or said cover, and an aperture in the other of said body portion and said cover. The post is also adapted to extend through the saw blade into the aperture to secure the saw blade to the device. The through holes are aligned when the post extends through the aperture and the aligned through holes are adapted to house a security hanger.

Abstract: A two-phase mixed media insulator having a dielectric fluid filling the interstices between macro-sized dielectric beads packed into a confined volume, so that the packed dielectric beads inhibit electro-hydrodynamically driven current flows of the dielectric liquid and thereby increase the resistivity and breakdown strength of the two-phase insulator over the dielectric liquid alone. In addition, an electrical apparatus incorporates the two-phase mixed media insulator to insulate between electrical components of different electrical potentials. And a method of electrically insulating between electrical components of different electrical potentials fills a confined volume between the electrical components with the two-phase dielectric composite, so that the macro dielectric beads are packed in the confined volume and interstices formed between the macro dielectric beads are filled with the dielectric liquid.

Abstract: This invention pertains to a multi-layered tablet for a triple combination release of active agents to an environment of use. More particularly, the invention pertains to a multi-layered tablet (1) comprising two external drug-containing layers (2 and 3) in stacked arrangement with respect to and on opposite sides of an oral dosage form (4) that provides a triple combination release of at least one active agent. In one embodiment of the invention the dosage form is an osmotic device. In another embodiment of the invention the dosage form is a gastro-resistant coated core. In yet another embodiment of the invention the dosage form is a matrix tablet. In a different embodiment the dosage form is a hard capsule.

Abstract: A method of retrieving a tool bit from a tool bit case includes supporting the tool bit with a bit retainer of the tool bit case at an oblique angle relative to a bottom surface of the tool bit case so that a drive portion of the tool bit extends generally away from the bottom surface, engaging the drive portion of the tool bit with a driver while the tool bit is supported by the bit retainer, and removing the tool bit from the bit retainer by manipulating the driver.

Abstract: The osmotic devices of the present invention contain a unitary core comprising a salt of amantadine and an osmotic salt, wherein the two salts have an ion in common. The release rate of the amantadine is a sigmoidal release. The osmotic device includes a semipermeable membrane having a controlled porosity that can be adapted as needed to cooperate with the osmotic salt in providing a predetermined drug release profile. The osmotic salt need not be coated and it is in admixture with the amantadine salt. The osmotic device further includes a drug-containing coat external to the semipermeable membrane. The osmotic device can include one or more additional drugs in the core and/or the drug-containing coat.

Abstract: A multi-function tool case includes a housing body having a wall extending from a first end to a second end. The wall includes an exterior surface and an interior surface. A cavity is defined by the interior surface and extends from the first end toward the second end. An extension member extends from the exterior surface adjacent the second end and defines a socket oriented along a tool axis for receiving a first portion of an accessory for retaining a tool bit. A cover assembly is coupled to the first end. The cover assembly includes a cap portion and a first lid member rotatably coupled to the cap portion. The cap portion and the lid member are configured to substantially enclose the cavity.

Abstract: The osmotic devices of the present invention contain a unitary core comprising a salt of amantadine and an osmotic salt, wherein the two salts have an ion in common. The release rate of the amantadine is a sigmoidal release. The osmotic device includes a semipermeable membrane having a controlled porosity that can be adapted as needed to cooperate with the osmotic salt in providing a predetermined drug release profile. The osmotic salt need not be coated and it is in admixture with the amantadine salt. The osmotic device further includes a drug-containing coat external to the semipermeable membrane. The osmotic device can include one or more additional drugs in the core and/or the drug-containing coat.

Abstract: A device for securing and displaying a saw blade, the device including a body portion having a first through hole adapted to receive a hanger, a cavity for housing a security device, and a locating profile. The device also includes a cover including a second through hole. The body portion and the cover are one structure coupled by a hinge such that the post extends from one of said body portion or said cover, and an aperture in the other of said body portion and said cover. The post is also adapted to extend through the saw blade into the aperture to secure the saw blade to the device. The through holes are aligned when the post extends through the aperture and the aligned through holes are adapted to house a security hanger.

Abstract: A neutron monitoring system uses a gamma thermometer to calibrate a nuclear instrument to ensure more accurate neutron flux measurements in a nuclear reactor core. The nuclear instrument generates a first signal proportional to a measured local neutron flux. The gamma thermometer generates a second signal proportional to a measured local gamma flux. A processor is used to compensate the second signal by filtering groups of delayed gamma sources to a reduced number of specific groups of delayed gamma sources. A third signal is calculated based upon yield fractions and time constants that are determined for the specific groups of delayed gamma sources. A gain of the nuclear instrument is calibrated based on a compensated second signal that is determined by subtracting the third signal from the second signal.

Abstract: The osmotic devices of the present invention include a single core comprising a salt of a drug and an osmotic salt, wherein the drug salt and the osmotic salt have a common ion. The release rate of the active drug is reduced, and the release profile of the active drug is modified, from a first order release profile to a zero order, pseudo-zero order, or sigmoidal release profile, by increasing the amount of the sodium chloride in the core of the device. In one embodiment the sodium chloride is used to modify a controlled release profile to a delayed and controlled release profile.

Abstract: An ultraminiature light source using a double-spiral shaped tungsten filament includes end contact portions which are separated to allow for radial and length-wise unwinding of the spiral. The double-spiral filament is spaced relatively far apart at the end portions thereof so that contact between portions of the filament upon expansion is avoided. The light source is made by fabricating a double-spiral ultraminiature tungsten filament from tungsten foil and housing the filament in a ceramic package having a reflective bottom and a well wherein the filament is suspended. A vacuum furnace brazing process attaches the filament to contacts of the ceramic package. Finally, a cover with a transparent window is attached onto the top of the ceramic package by solder reflow in a second vacuum furnace process to form a complete hermetically sealed package.

Abstract: The osmotic devices of the present invention contain a unitary core comprising a salt of amantadine and an osmotic salt, wherein the two salts have an ion in common. The release rate of the amantadine is modified from a first order release profile to a zero order, pseudo-zero order or sigmoidal release profile by increasing the amount of the osmotic salt in the core of the device. The osmotic device includes a semipermeable membrane having a controlled porosity that can be adapted as needed to cooperate with the osmotic salt in providing a predetermined drug release profile. The osmotic salt need not be coated and it is in admixture with the amantadine salt.

Abstract: A method of calibrating a nuclear instrument using a gamma thermometer may include: measuring, in the instrument, local neutron flux; generating, from the instrument, a first signal proportional to the neutron flux; measuring, in the gamma thermometer, local gamma flux; generating, from the gamma thermometer, a second signal proportional to the gamma flux; compensating the second signal; and calibrating a gain of the instrument based on the compensated second signal. Compensating the second signal may include: calculating selected yield fractions for specific groups of delayed gamma sources; calculating time constants for the specific groups; calculating a third signal that corresponds to delayed local gamma flux based on the selected yield fractions and time constants; and calculating the compensated second signal by subtracting the third signal from the second signal. The specific groups may have decay time constants greater than 5×10?1 seconds and less than 5×105 seconds.